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Abstract
Background Geriatric cachexia is distinct from other age-
related muscle wasting syndromes; however, detection and
therefore treatment is challenging without the availability of
valid instruments suitable for application in the clinical
setting. This study assessed the sensitivity and specificity
of a newly developed screening instrument utilising portable
assessments against previously defined and commonly ac-
cepted diagnostic criteria for detection of geriatric cachexia.
Methods Cross-sectional analyses from 71 older adults’
post-surgical fixation for hip fracture were performed. The
diagnostic criteria required measures of appendicular skele-
tal muscle index derived from dual-energy X-ray absorpti-
ometry and anorexia assessed by ≤70 % of estimated energy
requirements. These assessments were replaced with mid-
upper arm muscle circumference and the Simplified Nutri-
tional Appetite Questionnaire, respectively, to create a field
instrument suitable for screening geriatric cachexia. Sensi-
tivity, specificity and positive and negative predictive values
were calculated.
Results The current diagnostic algorithm identified few pa-
tients as cachectic (4/71; 5.6 %). The sensitivity and
specificity of the geriatric cachexia screening tool was 75
and 97 %, respectively. The screening tool had a positive
predictive value of 60 % and a negative predictive value of
99 %.
Conclusions Given the unexpected prevalence of ca-
chexia in such a vulnerable group, these results may
suggest problems in operationalising of the consensus
definition and diagnostic criteria. Although the applica-
tion of a newly developed screening tool using portable
field measures looks promising, the authors recommend
additional research to identify the prevalence of geriatric
cachexia, which captures all diagnostic criteria from the
consensus definition. Future investigation may then be
positioned to explore the predictive validity of screening
tools using portable field measures, which potentially
achieve higher sensitivity.
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1 Introduction
Age-related diseases associated with skeletal muscle atro-
phy have become one of the most extensively developed
topics of clinical investigation. Despite much research, the
aetiology of geriatric syndromes associated with skeletal
muscle wastage remains unclear [1, 2]. Despite progressive
losses in skeletal muscle mass (SMM) and function, i.e.
sarcopenia being a common characteristic of ageing [1, 3],
muscle wasting is not specific to age-related sarcopenia.
Physical inactivity [4], starvation [5, 6] and frailty [7, 8]
are all associated with skeletal muscle atrophy and therefore
should be distinguished from other forms of muscle wasting
syndromes such as cachexia.
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Older adults with recent hip fracture are an important
clinical group at increased risk of muscular disuse,
immobilisation, progressive disability, institutionalisation
and subsequent mortality post-surgery [9, 10]. Low SMM is
often present upon hospital admission among hip fracture
patients [11, 12], which often worsens throughout the admis-
sion [13]. Appropriate therapy is therefore paramount to fa-
cilitate improved health outcomes and increased participation
in rehabilitation in this cohort [14]. The effectiveness of a
more traditional nutritional approach such as energy and pro-
tein supplementation in this patient group, however, is not
convincing [11, 13]. Current evidence suggests that nutritional
supplementation alone may not prevent skeletal muscle
wasting in this group secondary to the pathophysiology of
cachexia [15, 16]. Therefore, the provision of appropriate
therapy depends on the accurate identification of cachexia.
In an older adult population, cachexia is infrequently
diagnosed and therefore rarely treated. A recent secondary
analysis from a sample of older adults aged ≥65 years
participating in ambulatory rehabilitation showed that one
in five participants (37/187) were defined as cachectic [17].
At the present time, cachexia lacks a universally accepted
definition, which represents a key issue for identification
and the provision of treatment. Independent of this, howev-
er, it is generally accepted that cachexia is a multi-factorial
syndrome associated with underlying illness characterised
by ongoing loss of body weight and skeletal muscle (with or
without fat mass), anorexia and systemic inflammation [2,
15, 16, 18]. The most commonly accepted consensus defi-
nition and set of diagnostic criteria published by the Society
of Sarcopenia, Cachexia and Wasting Disorders (SCWD)
allows clinicians and researchers to make a definitive diag-
nosis of cachexia [18]. For a clear diagnosis of cachexia,
however, one of the challenges for clinicians is the applica-
tion of easy, non-invasive portable field assessments. While
there are multiple clinical tools used for the assessment of
cancer cachexia [19–22], this is yet to be explored nor
validated in post-surgical older adults with limited mobility.
The purpose of this cross-sectional analysis was to pres-
ent preliminary evidence for the assessment of construct
validity of a newly developed screening tool utilising por-
table field methods against the previously defined diagnos-
tic criteria for detection of geriatric cachexia in community-
dwelling older adults’ post-surgical fixation for hip fracture.
2 Methods
2.1 Patients and recruitment
This was a cross-sectional analysis performed as part of the
INTERACTIVE trial (ACTRN 12607000017426), a prospec-
tive randomised controlled trial of a nutrition and exercise
programme in community-dwelling older adults’ post-
surgical fixation for hip fracture [23]. Participants were
recruited from three acute care settings including Flinders
Medical Centre, Adelaide, SA, Flinders Private Hospital, Ad-
elaide, SA and Hornsby Ku-ring-gai Hospital, Sydney, NSW
[23]. Data contributing to the final analyses were from baseline
measures, routinely performed within 14 days post-surgery.
Participants aged ≥65years were eligible for the study if
they were admitted with a diagnosis of hip fracture con-
firmed by radiology report, had a Mini-Mental State Exam-
ination score of ≥18, had a body mass index (BMI) between
18.5 and 35 kg/m2, and were community dwelling within
existing local service boundaries. Exclusion criteria includ-
ed a pathological fracture or malignancy, those residing in
residential care, non-English speaking, limited to stand
transfers only post-surgery or non-ambulatory pre-fracture,
unable to provide informed consent or deemed medically
unstable within 14 days post-surgery. This study was
conducted according to the guidelines described in the Dec-
laration of Helsinki, and all procedures involving human
subjects were approved by the Flinders Clinical Research
Ethics Committee (Protocol 110/067). Written informed
consent was obtained from all subjects.
2.2 Measurements and procedures
2.2.1 Cachexia diagnostic algorithm
In 2008, the SCWD published a commonly accepted consen-
sus definition in addition to a set of diagnostic criteria for a
diagnosis of cachexia [18]. Weight loss (e.g. BMI ≤20kg m2,
or loss of body weight ≥5 % within the previous 12 months or
less) is the cornerstone of this consensus definition [18].
Furthermore, the presence of at least three of the following
criteria, i.e. decreased muscle strength, fatigue, anorexia, low
appendicular skeletal muscle (ASM) index and abnormal
biochemical parameters (inflammation, anaemia or low albu-
min), is required for a diagnosis of cachexia [18]. The diag-
nostic algorithm and diagnostic cut-offs established by the
SCWD are shown in Fig. 1. Measures of ASM index (male,
≤7.25kg; female, ≤5.45kg), recorded dietary intake ≤70 % of
estimated energy requirements and isometric hand-grip
strength (lowest tertile for grip strength; male, ≤27.3 kg; fe-
male, ≤16.3 kg) coupled with a BMI ≤22 kg m2 were used as
the diagnostic algorithm for the detection of cachexia in the
present study (Fig. 1). A BMI≤22kg m2, rather than
≤20 kg m2 was used as the critical level of BMI for older
adults in the present study [24–26].
2.3 Weight and height
Body weight was recorded to the nearest 0.1 kg using
calibrated digital scales (Tanita, BF-681 Scale and Body
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Fat Monitor, Tokyo, Japan) with participants wearing light
clothing and without footwear. Participants unable to mobi-
lise were weighed using a calibrated weigh chair. Knee
height was measured on the non-injured leg with partici-
pants wearing no footwear with the participant in a supine or
seated position. Height was estimated from knee height
using validated age and gender specific equations [27, 28].
BMI was calculated as weight (kilogram) divided by the
square of height (metre).
2.4 Dual-energy X-ray absorptiometry
Whole-body and regional body composition was estimated
using dual-energyX-ray absorptiometry (DEXA) (Lunar Prod-
igy, GE Healthcare, UK) with the automated reporting GE
EnCORE bone densitometry software (version 10.51.006).
The system software provides estimates of FFM, lean soft
tissue, fat mass and bone mineral density for total body and
body segments including both arms, both legs and the trunk.
ASMwas calculated as the sum of lean soft tissue mass in both
arms and legs [29] with the ASM index calculated using the
formula, ASM/height2 (kg/m2) [30]. Prior to all DEXA scans,
all participants underwent a DEXA screening checklist to
ensure safety and validity of the technique. Participants were
excluded from the DEXA scan if they reported a history of
nuclear scans or other X-ray examinations in the previous 0–
14 days or had a recorded body weight ≥130 kg. Prior to the
scan, all participants were asked to remove all metal accesso-
ries, were asked to identify any medications taken in the
previous 24 h (including calcium or iron supplements) and
were asked to identify any history of previous fracture and/or
metal implants. The software recognises metal in the body,
Fig. 1 Diagnostic algorithm for
cachexia established by the
Society of Sarcopenia,
Cachexia and Wasting
Disorders (SCWD) and the
proposed new screening tool for
detection of geriatric cachexia
in hip fracture patients. In the
present study, the newly
developed screening tool was
assessed against three
diagnostic measures from the
diagnostic algorithm for
cachexia. BMI body mass
index, FFM fat-free mass, ASM
appendicular skeletal muscle,






cutoffs from the proposed
diagnostic algorithm for
cachexia were derived from
Evans et al. [18]. b Screening
tool diagnostic criteria cut-offs
for isometric hand-grip strength
and MUAMC were obtained
from wave 1 of the Australian
Longitudinal Study of Ageing
(ALSA) [35]. c A score ≤14 for
SNAQ identifies persons with
anorexia at risk of significant
weight loss of at least 5 %
within 6 months [38]
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such as artificial joints, allowing exclusion from calculations
prior to analysis. Participants were dressed in hospital gowns
and positioned in a supine position on the table top with their
feet in a neutral position with hands flat by their sides. All
DEXA scans were performed by a licenced technician.
2.5 Dietary intake and analyses
Dietary intake was assessed using a single multiple-pass 24-
h dietary recall. Hospital ready-reckoners were used to
estimate energy and protein intake. Individual estimated
energy requirements were calculated using gender-specific
Harris–Benedict equations [31] to estimate resting metabol-
ic rate, with adjustments made for physical activity (1.2),
trauma (1.35) and weight gain (0.25 kg/week) [32]. All
dietary analyses were performed by an accredited practising
dietitian.
2.6 Isometric hand-grip strength
Isometric hand-grip strength was used as a reliable and valid
surrogate measure of muscle strength [33, 34] for the diag-
nostic algorithm and in the development of the screening
tool. Grip-strength was measured in the dominant hand with
a calibrated Smedley Hand Dynamometer (Tokyo, Japan).
All measures were performed on three separate occasions
with ~60-s rest intervals between each measure with the
mean of the three measures used for analyses. All measures
were recorded to the nearest 0.1 kg.
2.7 Development of cachexia screening tool
In keeping with the cachexia diagnostic algorithm, BMI
≤22 kg m2 and isometric hand-grip strength were
maintained in the newly developed screening tool. Measures
of ASM index derived from DEXA and anorexia assessed
by 24-h dietary recall in the diagnostic algorithm were
replaced with portable assessments of body composition
and anorexia including mid-upper arm muscle circumfer-
ence (MUAMC) and the Simplified Nutritional Appetite
Questionnaire (SNAQ), respectively. Diagnostic cut-off
criteria for isometric hand-grip strength (lowest tertile for
grip strength; male, ≤27.3 kg; female, ≤16.3 kg) and
MUAMC (≤25th percentile; male, ≤23.49 cm; female,
≤20.84 cm) were derived from age and gender specific data
obtained from wave 1 of the Australian Longitudinal Study
on Ageing [35]. The newly developed screening tool and
specific diagnostic cut-offs are shown in Fig. 1.
2.8 Upper-arm anthropometry
MUAMC is derived from two upper-arm anthropometric
techniques, MUAC and triceps skinfold thickness (TSF).
MUAC was measured to the nearest 0.1 cm using a flexible
steel measuring tape (KDS Corporation, Kyoto, Japan), and
TSF was measured to the nearest 0.2 mm using a calibrated
Harpenden skinfold calliper (Baty, International Sussex,
UK). All anthropometric measures were performed by
trained dietitians and/or physiotherapists, with each measure
performed on three separate occasions with the mean of the
three measures used for analyses. Unless affected by injury,
all anthropometric measures were taken on the right-hand
side of the body. MUAMC was estimated from TSF (mm)
thickness and MUAC (cm) using the formula: MUAMC=
MUAC(cm)−0.3142×TSF(mm) [36, 37].
2.9 Appetite
Appetite was assessed using the SNAQ; a quick and feasible
four-item derivative of the eight-item Council on Nutrition
Appetite Questionnaire developed by the Council for Nutri-
tional Strategies in Long-Term Care in institutionalised and
community-dwelling older adults [38]. The SNAQ takes
approximately ~1 min to complete and was administered
either by trained dietitians and/or physiotherapists. Partici-
pants were asked to respond to the four-item questionnaire,
which included a self-rating of appetite, satiation, gustation
and the frequency of meals eaten throughout the day. The
total SNAQ score is the sum of scores from the four items,
with lower scores indicating deterioration in appetite. Pos-
sible scores range from 4 (worst) to 20 (best). A score of ≤14
for the four-item questionnaire identifies persons with an-
orexia at risk of significant weight loss of at least 5 % within
6 months [38].
2.10 Statistical analyses
Analyses were performed using SPSS for Windows 17.0
software (SPSS Inc, Chicago, IL, USA). Contingency tables
were used to determine the specificity, sensitivity and pre-
dictive values for the screening tool as a function of its
ability to predict geriatric cachexia against the commonly
accepted diagnostic algorithm. For continuous data, mean
(SD) were reported with frequencies and percentages
reported for categorical data. Independent samples t tests
were used to assess gender differences for each diagnostic
parameter of cachexia. Significance was set at P<0.05.
3 Results
A sample of 71 older adults (female, n=52; male, n=19)
recruited from the INTERACTIVE trial with DEXA results
available were included in the final analyses. The mean±SD
age of participants at baseline was 82.2±5.8 years. The
primary measures of interest in the present study are shown
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in Table 1. Significant gender differences were observed
with women having greater TSF thickness (P=0.001) and
BMI (P=0.03); men, however, had significantly greater
isometric hand-grip strength (P<0.001) relative to women.
The newly developed screening tool identified ~7 % of
participants as cachectic (5/71) compared with ~5.5 %
(4/71) by the consensus definition. By comparison with
the consensus definition, the screening tool correctly iden-
tified three participants as cachectic (i.e. true positives) and
classified 65 participants as non-cachectic (i.e. true nega-
tives). Two participants were falsely classified as cachectic
by the screening tool. The sensitivity and specificity of the
screening tool was 75 and 97 %, respectively. The screening
tool had a positive predictive value of 60 % and a negative
predictive value of 99 %. The number of participants scor-
ing positively (i.e. below the diagnostic parameters) on
cachexia features is shown in Table 2.
4 Discussion
This study assessed the sensitivity and specificity of a newly
developed screening tool in older adults’ post-surgical
fixation for hip fracture. These preliminary findings demon-
strate that the screening instrument displays sufficient levels
of agreement when applied against the commonly accepted
diagnostic algorithm with a sensitivity and specificity of 75
and 97 %, respectively. However, unexpectedly, only 1 in 20
older adults with hip fracture were identified as cachectic
when the diagnostic algorithm was applied.
Age-related diseases such as cachexia are of high interest
to clinicians at present, but there are gaps in operationalising
the approach; a key gap at the present time in the application
of the consensus definition is a thorough investigation of its
clinical usefulness and effectiveness in a variety of
populations [39]. The prevalence of cachexia in chronic
conditions such as cancer, chronic heart failure, chronic
kidney disease, rheumatoid arthritis and chronic obstructive
pulmonary disease has previously been reported [39]. How-
ever, little is known about the prevalence of cachexia in an
ageing population. Yaxley et al. [17] recently identified one
in five older adults participating in ambulatory rehabilitation
as cachectic. In contrast to the present study, however,
Yaxley et al. [17] used different diagnostic measures to
those that were used in the present study [18].
To our knowledge, this is the first study to assess the
construct validity of a newly developed screening tool
utilising portable field methods against the commonly ac-
cepted consensus definition for the detection of geriatric
cachexia. Previously due to the lack of a formal cachexia
screening instrument, malnutrition screening tools such as
the Mini Nutritional Assessment have been proposed for a
timely diagnosis [40, 41]. However, using nutrition assess-
ment tools alone for a diagnosis of geriatric cachexia is
inappropriate if they are not validated against the diagnostic
algorithm of the consensus definition. Impaired regulation
of appetite and decreased energy intake with ageing is a
common phenomenon among older adults, often described
as the anorexia of ageing [6, 16, 42]. Consequently, a non-
specific diagnosis of malnutrition, particularly in an older
orthopaedic population, may result in the mis-diagnosis of
severe wasting disease such as cachexia and therefore not
conducive to the provision of timely and appropriate thera-
py. Using the same consensus framework used in the present
study, a recent exploratory analysis in patients with stage III
non-small-cell lung cancer, cachexia was present in 11 of 40
(28 %) patients [43]. These investigators also reported that
~50 % of non-cachectic patients scored positively on ca-
chexia features including moderate weight loss, systemic
inflammation, anorexia and reduced handgrip strength
[43]. In the present study, we reported similar findings for
diagnostic parameters including anorexia, isometric grip
strength and MUAMC. Furthermore, the previous study by
van der Meij et al. [43] also reported issues in the
operationalising of the consensus definition whereby cancer
patients presenting with ≥5 % weight loss in combination
Table 1 Characteristics for each diagnostic parameter of cachexia at
baseline post-surgical fixation for hip fracture in male and female
participants (all such values reported as mean±SD)
Characteristics Mean SD
Male, n=19
Weight (kg) 69.7 12.7
BMI (kg m2)a 23.9 2.9
MUAC (cm) 26.7 3.3
TSF (mm)a 11.5 4.8
MUAMC (cm) 23.2 2.5
ASM Index (kg m2) 6.7 0.9
SNAQ score 13.6 2.9
Isometric hand-grip strength (kg)a 23.9 7.6
Female, n=52
Weight (kg) 66.4 12.9
BMI (kg m2)a 25.9 3.8
MUAC (cm) 27.1 3.9
TSF (mm)a 16.4 5.4
MUAMC (cm) 21.9 3.1
ASM Index (kg m2) 6.4 0.9
SNAQ score 13.1 2.2
Isometric hand-grip strength (kg)a 15.9 4.7
BMI body mass index, MUAC mid-upper arm circumference, TSF
triceps skinfold thickness, MUAMC mid-upper arm muscle circumfer-
ence, ASM appendicular skeletal muscle, SNAQ Simplified Nutritional
Appetite Questionnaire
a Significant differences between men and women by independent
samples t test (P<0.05)
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with two positive characteristics of cachexia were classified
as non-cachectic by the consensus framework.
While the prevalence of cachexia in this group was
somewhat unexpected, there are some important consider-
ations that should be applied in the interpretation of these
results. One important consideration was the potential for
selection bias at study entry (i.e. BMI between 18.5 and
35 kg/m2, community dwelling, medically stable and ambu-
latory pre-fracture) resulting in potential cachectic patients
being excluded. In the present study, we used BMI of
≤22 kg m2 as the critical level of BMI; given the mean
BMI of this cohort (male, 23.9 kg m2; female, 25.9 kg m2)
and a lack of access to weight loss history of participants
pre-surgery, potential cachectic patients may have been
misdiagnosed as non-cachectic. It is widely recognised that
BMI is an indirect and imperfect measure of assessing body
composition. This may be particularly true in an older adult
population where lean and fat mass both act as important
nutritional preserves during times of illness [25]. Moreover,
there is evidence that current BMI classifications may be
overly restrictive in older adults, suggesting that BMI
thresholds should be re-evaluated further [25, 44]. Specifi-
cally, results from the present study revealed few patients
with BMI ≤22 kg m2, yet almost three quarters of the study
population reported SNAQ scores ≤14, suggesting increased
risk of significant weight loss within 6 months [38]. Despite
this, it may be argued that the timing of administering the
SNAQ and the subsequent SNAQ score in postoperative
older adults does not accurately reflect chronic anorexia
given that it is a measure of recent dietary intake.
Of clinical and diagnostic importance, abnormal bio-
chemical parameters including markers of inflammation, a
key clinical characteristic of cachexia [15, 16, 18], were not
included in our screening instrument. Although blood anal-
yses are not necessarily a practical field measure, their
exclusion in the present study may be an important factor
contributing to the underestimation of geriatric cachexia in
this sample of hip fracture patients. However, despite a
wealth of literature suggesting that systemic inflammation
plays a role in the pathogenesis of cachexia and ageing [2,
16, 45, 46], in the present study, there is potential for
overlap between post-operative transient inflammation and
systemic inflammation resulting from other aetiologies.
Irrespective of the potential limitations, we report an
acceptable sensitivity (75 %) and high specificity (97 %)
for the application of a screening tool utilising portable field
methods against the previously defined diagnostic criteria in
the acute care setting. The application of validated portable
field instruments coupled with diagnostic measures includ-
ing weight loss history (i.e. ≥5 % in 12 months or less) and
markers of inflammation may be of clinical importance for a
diagnosis of cachexia in an older orthopaedic population.
Although DEXA is commonly referred to as the reference
technique for assessing body composition, its high cost, lack
of access and the difficulty of positioning post-surgical
patients in the correct position for measurement secondary
to pain and immobility make this method not always prac-
tical for older adults recovering from orthopaedic surgery
[12, 47]. Alternatively, upper arm anthropometry is a quick,
inexpensive and portable method of assessing body compo-
sition and nutritional status in older adults [48–50]. Further-
more, an advantage of the SNAQ when compared against
other geriatric assessment tools or dietary recall is its feasi-
bility in the clinical environment. The SNAQ has previously
been validated for application in older adults for the identi-
fication of anorexia and as a predictor of significant weight
loss of at least 5 % within 6 months [38, 51].
In conclusion, this study provides preliminary evidence
of the difficulty in identifying cachexia in an older adult
population using current diagnostic criteria. Validation of
geriatric cachexia screening instruments remains a necessity,
however, a “gold standard” is still lacking. Further
Table 2 Frequency (percentage) of hip fracture patients (n=71) presenting above or below each diagnostic parameter for geriatric cachexia
Diagnostic parameters Above diagnostic criteria (n, %) Below diagnostic criteria (n, %)
BMI ≤22 kg m2 61 (85.9 %) 10 (14.1 %)
ASM index (kg m2): ≤7.25 men; ≤5.45 womena 49 (69 %) 22 (31 %)
Isometric grip-strength: ≤27.3kg men; ≤16.3 kg womenb 31 (43.7 %) 40 (56.3 %)
Dietary energy intake ≤70 % estimated energy requirementsa 42 (59.2 %) 29 (40.8 %)
SNAQ score ≤14c 21 (29.6 %) 50 (70.4 %)
MUAMC: ≤23.49 cm men; ≤20.84 womenb (n=142) 39 (54.9 %) 32 (45.1 %)
BMI body mass index, ASM appendicular skeletal muscle, SNAQ Simplified Nutritional Appetite Questionnaire, MUAMC mid-upper arm muscle
circumference
a Diagnostic cut-offs from the proposed diagnostic algorithm for cachexia were derived from Evans et al. [18]
b Screening tool diagnostic criteria cut-offs for isometric hand-grip strength and MUAMC were obtained from wave 1 of the Australian
Longitudinal Study of Ageing (ALSA) [35]
c A score ≤14 for SNAQ identifies persons with anorexia at risk of significant weight loss of at least 5 % within 6 months [38]
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prospective research in a heterogeneous group of hip frac-
ture patients, which captures all diagnostic criteria from the
consensus definition to identify the prevalence of cachexia
that is closer to the expected, would be of benefit. Future
investigation may then be positioned to explore the predic-
tive validity of screening tools that use non-invasive, porta-
ble field measures for the identification of geriatric
cachexia, which potentially achieve higher sensitivity.
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